{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,7,18]],"date-time":"2026-07-18T04:04:26Z","timestamp":1784347466400,"version":"3.55.0"},"reference-count":49,"publisher":"Springer Science and Business Media LLC","issue":"8","license":[{"start":{"date-parts":[[2026,7,18]],"date-time":"2026-07-18T00:00:00Z","timestamp":1784332800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"},{"start":{"date-parts":[[2026,7,18]],"date-time":"2026-07-18T00:00:00Z","timestamp":1784332800000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"}],"funder":[{"DOI":"10.13039\/501100004731","name":"Natural Science Foundation of Zhejiang Province","doi-asserted-by":"publisher","award":["LTGY24H160011"],"award-info":[{"award-number":["LTGY24H160011"]}],"id":[{"id":"10.13039\/501100004731","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100001809","name":"National Natural Science Foundation of China","doi-asserted-by":"publisher","award":["82171827"],"award-info":[{"award-number":["82171827"]}],"id":[{"id":"10.13039\/501100001809","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Human Cell"],"DOI":"10.1007\/s13577-026-01426-9","type":"journal-article","created":{"date-parts":[[2026,7,18]],"date-time":"2026-07-18T01:54:55Z","timestamp":1784339695000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":0,"title":["Targeting eIF5A2 hypusination with bikinin sensitizes hepatocellular carcinoma to lenvatinib by suppressing TFEB-mediated autophagy"],"prefix":"10.1007","volume":"39","author":[{"given":"Shuqian","family":"Wang","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Qingyun","family":"Zhou","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Qiaomei","family":"Lin","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Shufen","family":"Zhang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ying","family":"Cai","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Fangnan","family":"Wu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Fangyuan","family":"Kuang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Lianghui","family":"Wang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Shangzhi","family":"Xie","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jiahua","family":"Lan","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Li","family":"Zheng","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Guodong","family":"Xu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Chuxiao","family":"Shao","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-0399-6216","authenticated-orcid":false,"given":"Wei","family":"Chen","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Chaoyong","family":"Tu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2026,7,18]]},"reference":[{"key":"1426_CR1","doi-asserted-by":"publisher","first-page":"629","DOI":"10.1007\/s10555-023-10084-4","volume":"42","author":"Y Wang","year":"2023","unstructured":"Wang Y, Deng B. Hepatocellular carcinoma: molecular mechanism, targeted therapy, and biomarkers. Cancer Metastasis Rev. 2023;42:629\u201352.","journal-title":"Cancer Metastasis Rev"},{"key":"1426_CR2","doi-asserted-by":"publisher","DOI":"10.1016\/j.jhepr.2024.101130","volume":"6","author":"A Childs","year":"2024","unstructured":"Childs A, Aidoo-Micah G, Maini MK, Meyer T. Immunotherapy for hepatocellular carcinoma. JHEP Rep. 2024;6:101130.","journal-title":"JHEP Rep"},{"key":"1426_CR3","doi-asserted-by":"publisher","first-page":"29","DOI":"10.1016\/j.cytogfr.2024.08.006","volume":"79","author":"B Yu","year":"2024","unstructured":"Yu B, Ma W. Biomarker discovery in hepatocellular carcinoma (HCC) for personalized treatment and enhanced prognosis. Cytokine Growth Factor Rev. 2024;79:29\u201338.","journal-title":"Cytokine Growth Factor Rev"},{"key":"1426_CR4","doi-asserted-by":"publisher","DOI":"10.1186\/s12943-024-02101-z","volume":"23","author":"YT Chan","year":"2024","unstructured":"Chan YT, Zhang C, Wu J, et al. Biomarkers for diagnosis and therapeutic options in hepatocellular carcinoma. Mol Cancer. 2024;23:189.","journal-title":"Mol Cancer"},{"key":"1426_CR5","doi-asserted-by":"publisher","first-page":"926","DOI":"10.1097\/HEP.0000000000000237","volume":"79","author":"AD Ladd","year":"2024","unstructured":"Ladd AD, Duarte S, Sahin I, Zarrinpar A. Mechanisms of drug resistance in HCC. Hepatology. 2024;79:926\u201340.","journal-title":"Hepatology"},{"key":"1426_CR6","doi-asserted-by":"publisher","first-page":"1239","DOI":"10.1007\/s11864-024-01246-9","volume":"25","author":"H Dong","year":"2024","unstructured":"Dong H, Zhang Z, Ni M, et al. The trend of the treatment of advanced hepatocellular carcinoma: combination of immunotherapy and targeted therapy. Curr Treat Options Oncol. 2024;25:1239\u201356.","journal-title":"Curr Treat Options Oncol"},{"key":"1426_CR7","doi-asserted-by":"publisher","first-page":"4059","DOI":"10.3390\/cancers16234059","volume":"16","author":"K Krupa","year":"2024","unstructured":"Krupa K, Fudalej M, Cencelewicz-Lesikow A, Badowska-Kozakiewicz A, Czerw A, Deptala A. Current treatment methods in hepatocellular carcinoma. Cancers (Basel). 2024;16:4059.","journal-title":"Cancers (Basel)."},{"key":"1426_CR8","doi-asserted-by":"publisher","DOI":"10.1016\/j.bbcan.2020.188391","volume":"1874","author":"Y Zhao","year":"2020","unstructured":"Zhao Y, Zhang YN, Wang KT, Chen L. Lenvatinib for hepatocellular carcinoma: from preclinical mechanisms to anti-cancer therapy. Biochim Biophys Acta Rev Cancer. 2020;1874:188391.","journal-title":"Biochim Biophys Acta Rev Cancer"},{"key":"1426_CR9","doi-asserted-by":"publisher","first-page":"1885","DOI":"10.1042\/BST20221035","volume":"50","author":"AP Sfakianos","year":"2022","unstructured":"Sfakianos AP, Raven RM, Willis AE. The pleiotropic roles of eIF5A in cellular life and its therapeutic potential in cancer. Biochem Soc Trans. 2022;50:1885\u201395.","journal-title":"Biochem Soc Trans"},{"key":"1426_CR10","doi-asserted-by":"publisher","DOI":"10.1038\/s41419-023-06109-z","volume":"14","author":"J Zeng","year":"2023","unstructured":"Zeng J, Ye Z, Shi S, et al. Targeted inhibition of eIF5A(hpu) suppresses tumor growth and polarization of M2-like tumor-associated macrophages in oral cancer. Cell Death Dis. 2023;14:579.","journal-title":"Cell Death Dis"},{"key":"1426_CR11","doi-asserted-by":"publisher","first-page":"301","DOI":"10.1093\/protein\/gzq110","volume":"24","author":"JH Park","year":"2011","unstructured":"Park JH, Dias CA, Lee SB, et al. Production of active recombinant eIF5A: reconstitution in E.coli of eukaryotic hypusine modification of eIF5A by its coexpression with modifying enzymes. Protein Eng Des Sel. 2011;24:301\u20139.","journal-title":"Protein Eng Des Sel"},{"key":"1426_CR12","doi-asserted-by":"publisher","first-page":"562","DOI":"10.1136\/gutjnl-2011-300207","volume":"61","author":"W Zhu","year":"2012","unstructured":"Zhu W, Cai MY, Tong ZT, et al. Overexpression of EIF5A2 promotes colorectal carcinoma cell aggressiveness by upregulating MTA1 through C-myc to induce epithelial-mesenchymaltransition. Gut. 2012;61:562\u201375.","journal-title":"Gut"},{"key":"1426_CR13","doi-asserted-by":"publisher","DOI":"10.1186\/s13287-021-02256-2","volume":"12","author":"K Wang","year":"2021","unstructured":"Wang K, Wang Y, Wang Y, et al. EIF5A2 enhances stemness of epithelial ovarian cancer cells via a E2F1\/KLF4 axis. Stem Cell Res Ther. 2021;12:186.","journal-title":"Stem Cell Res Ther"},{"key":"1426_CR14","doi-asserted-by":"publisher","first-page":"70","DOI":"10.1186\/s13578-021-00578-5","volume":"11","author":"G Zhao","year":"2021","unstructured":"Zhao G, Zhang W, Dong P, et al. EIF5A2 controls ovarian tumor growth and metastasis by promoting epithelial to mesenchymal transition via the TGFbeta pathway. Cell Biosci. 2021;11:70.","journal-title":"Cell Biosci"},{"key":"1426_CR15","doi-asserted-by":"publisher","DOI":"10.1038\/s41419-022-05033-y","volume":"13","author":"G Xu","year":"2022","unstructured":"Xu G, Chen H, Wu S, et al. Eukaryotic initiation factor 5A2 mediates hypoxia-induced autophagy and cisplatin resistance. Cell Death Dis. 2022;13:683.","journal-title":"Cell Death Dis"},{"key":"1426_CR16","doi-asserted-by":"publisher","first-page":"1167","DOI":"10.24976\/Discov.Med.202335179.113","volume":"35","author":"J Yang","year":"2023","unstructured":"Yang J, Jiang X, Chen Y, Teng L. EIF5A2 promotes doxorubicin resistance in bladder cancer cells through the TGF-beta signaling pathway. Discov Med. 2023;35:1167\u201376.","journal-title":"Discov Med"},{"key":"1426_CR17","doi-asserted-by":"publisher","DOI":"10.1016\/j.tranon.2022.101351","volume":"18","author":"L Jiang","year":"2022","unstructured":"Jiang L, Zhang Y, Su P, et al. Long non-coding RNA HNF1A-AS1 induces 5-FU resistance of gastric cancer through miR-30b-5p\/EIF5A2 pathway. Transl Oncol. 2022;18:101351.","journal-title":"Transl Oncol"},{"key":"1426_CR18","doi-asserted-by":"publisher","first-page":"1013","DOI":"10.7150\/ijbs.7191","volume":"9","author":"FW Wang","year":"2013","unstructured":"Wang FW, Guan XY, Xie D. Roles of eukaryotic initiation factor 5A2 in human cancer. Int J Biol Sci. 2013;9:1013\u201320.","journal-title":"Int J Biol Sci"},{"key":"1426_CR19","first-page":"1283","volume":"39","author":"L Fang","year":"2018","unstructured":"Fang L, Gao L, Xie L, Xiao G. GC7 enhances cisplatin sensitivity via STAT3 signaling pathway inhibition and eIF5A2 inactivation in mesenchymal phenotype oral cancer cells. Oncol Rep. 2018;39:1283\u201391.","journal-title":"Oncol Rep"},{"key":"1426_CR20","doi-asserted-by":"publisher","first-page":"871","DOI":"10.1016\/j.cell.2009.11.007","volume":"139","author":"JP Thiery","year":"2009","unstructured":"Thiery JP, Acloque H, Huang RY, Nieto MA. Epithelial-mesenchymal transitions in development and disease. Cell. 2009;139:871\u201390.","journal-title":"Cell"},{"key":"1426_CR21","doi-asserted-by":"publisher","first-page":"1701","DOI":"10.1053\/j.gastro.2014.02.029","volume":"146","author":"Y Li","year":"2014","unstructured":"Li Y, Fu L, Li JB, et al. Increased expression of EIF5A2, via hypoxia or gene amplification, contributes to metastasis and angiogenesis of esophageal squamous cell carcinoma. Gastroenterology. 2014;146:1701-13 e9.","journal-title":"Gastroenterology"},{"key":"1426_CR22","doi-asserted-by":"publisher","first-page":"579","DOI":"10.7150\/ijbs.29775","volume":"15","author":"Y Liu","year":"2019","unstructured":"Liu Y, Lei P, Qiao H, et al. MiR-9 enhances the chemosensitivity of AML cells to daunorubicin by targeting the EIF5A2\/MCL-1 axis. Int J Biol Sci. 2019;15:579\u201386.","journal-title":"Int J Biol Sci"},{"key":"1426_CR23","doi-asserted-by":"publisher","first-page":"165","DOI":"10.3892\/or.2020.7608","volume":"44","author":"Y Xu","year":"2020","unstructured":"Xu Y, Liu Y, Li Z, et al. Long non\u2011coding RNA H19 is involved in sorafenib resistance in hepatocellular carcinoma by upregulating miR\u2011675. Oncol Rep. 2020;44:165\u201373.","journal-title":"Oncol Rep"},{"key":"1426_CR24","doi-asserted-by":"publisher","first-page":"1097","DOI":"10.1097\/CAD.0000000000000550","volume":"28","author":"Y Liu","year":"2017","unstructured":"Liu Y, Xue F, Zhang Y, et al. N1-guanyl-1,7-diaminoheptane enhances the chemosensitivity of acute lymphoblastic leukemia cells to vincristine through inhibition of eif5a-2 activation. Anticancer Drugs. 2017;28:1097\u2013105.","journal-title":"Anticancer Drugs"},{"key":"1426_CR25","doi-asserted-by":"publisher","first-page":"64","DOI":"10.1007\/s12020-019-02173-8","volume":"68","author":"H Guo","year":"2020","unstructured":"Guo H, Shen Y, Kong YH, et al. The expression of Tim-1 and Tim-4 molecules in regulatory T cells in type 1 diabetes. Endocrine. 2020;68:64\u201370.","journal-title":"Endocrine"},{"key":"1426_CR26","doi-asserted-by":"publisher","first-page":"1151","DOI":"10.7150\/thno.38327","volume":"10","author":"Y Wu","year":"2020","unstructured":"Wu Y, Tang YX, Xie SZ, et al. Chimeric peptide supramolecular nanoparticles for plectin-1 targeted miRNA-9 delivery in pancreatic cancer. Theranostics. 2020;10:1151\u201365.","journal-title":"Theranostics"},{"key":"1426_CR27","doi-asserted-by":"publisher","first-page":"110","DOI":"10.1016\/j.molcel.2019.08.005","volume":"76","author":"H Zhang","year":"2019","unstructured":"Zhang H, Alsaleh G, Feltham J, et al. Polyamines control eIF5A hypusination, TFEB translation, and autophagy to reverse B cell senescence. Mol Cell. 2019;76:110-25 e9.","journal-title":"Mol Cell"},{"key":"1426_CR28","doi-asserted-by":"publisher","first-page":"3608","DOI":"10.7150\/ijbs.64003","volume":"17","author":"S Zhao","year":"2021","unstructured":"Zhao S, Zhang Y, Lu X, et al. CDC20 regulates the cell proliferation and radiosensitivity of P53 mutant HCC cells through the Bcl-2\/Bax pathway. Int J Biol Sci. 2021;17:3608\u201321.","journal-title":"Int J Biol Sci"},{"key":"1426_CR29","doi-asserted-by":"publisher","DOI":"10.1016\/j.ijpharm.2024.123889","volume":"653","author":"S Samia","year":"2024","unstructured":"Samia S, Sandeep Chary P, Khan O, Kumar Mehra N. Recent trends and advances in novel formulations as an armament in Bcl-2\/Bax targeted breast cancer. Int J Pharm. 2024;653:123889.","journal-title":"Int J Pharm"},{"key":"1426_CR30","doi-asserted-by":"publisher","first-page":"827","DOI":"10.7150\/ijbs.32460","volume":"16","author":"Y Bao","year":"2020","unstructured":"Bao Y, Zhang Y, Lu Y, et al. Overexpression of microRNA-9 enhances cisplatin sensitivity in hepatocellular carcinoma by regulating EIF5A2-mediated epithelial-mesenchymal transition. Int J Biol Sci. 2020;16:827\u201337.","journal-title":"Int J Biol Sci"},{"key":"1426_CR31","doi-asserted-by":"publisher","first-page":"129","DOI":"10.1016\/j.canlet.2018.08.010","volume":"436","author":"T Ma","year":"2018","unstructured":"Ma T, Chen W, Zhi X, et al. USP9X inhibition improves gemcitabine sensitivity in pancreatic cancer by inhibiting autophagy. Cancer Lett. 2018;436:129\u201338.","journal-title":"Cancer Lett"},{"key":"1426_CR32","doi-asserted-by":"publisher","first-page":"730","DOI":"10.1038\/s41586-021-03741-7","volume":"595","author":"H Jin","year":"2021","unstructured":"Jin H, Shi Y, Lv Y, et al. EGFR activation limits the response of liver cancer to lenvatinib. Nature. 2021;595:730\u20134.","journal-title":"Nature"},{"key":"1426_CR33","doi-asserted-by":"publisher","first-page":"2025","DOI":"10.1038\/s41388-025-03371-7","volume":"44","author":"GP Zhang","year":"2025","unstructured":"Zhang GP, Song ZB, Chen DH, et al. Syntaxin-6 mediated autophagy confers lenvatinib resistance in hepatocellular carcinoma. Oncogene. 2025;44:2025\u201339.","journal-title":"Oncogene"},{"key":"1426_CR34","doi-asserted-by":"publisher","DOI":"10.1016\/j.phymed.2023.155091","volume":"122","author":"M Liao","year":"2024","unstructured":"Liao M, Qin M, Liu L, et al. Exosomal microRNA profiling revealed enhanced autophagy suppression and anti-tumor effects of a combination of compound Phyllanthus urinaria and lenvatinib in hepatocellular carcinoma. Phytomedicine. 2024;122:155091.","journal-title":"Phytomedicine"},{"key":"1426_CR35","doi-asserted-by":"publisher","DOI":"10.3390\/cancers13215575","author":"I Ganzleben","year":"2021","unstructured":"Ganzleben I, Neurath MF, Becker C. Autophagy in cancer therapy-molecular mechanisms and current clinical advances. Cancers (Basel). 2021. https:\/\/doi.org\/10.3390\/cancers13215575.","journal-title":"Cancers (Basel)"},{"key":"1426_CR36","doi-asserted-by":"publisher","first-page":"9590","DOI":"10.18632\/aging.205037","volume":"15","author":"S Wang","year":"2023","unstructured":"Wang S, Nie J, Xu K, et al. YY1 is regulated by ALKBH5-mediated m6A modification and promotes autophagy and cancer progression through targeting ATG4B. Aging (Albany NY). 2023;15:9590\u2013613.","journal-title":"Aging (Albany NY)"},{"key":"1426_CR37","doi-asserted-by":"publisher","DOI":"10.3389\/fimmu.2024.1412781","volume":"15","author":"Y Li","year":"2024","unstructured":"Li Y, Yin Y, Zhang T, et al. A comprehensive landscape analysis of autophagy in cancer development and drug resistance. Front Immunol. 2024;15:1412781.","journal-title":"Front Immunol"},{"key":"1426_CR38","doi-asserted-by":"publisher","DOI":"10.1016\/j.ctrv.2020.102043","volume":"88","author":"L Mele","year":"2020","unstructured":"Mele L, Del Vecchio V, Liccardo D, et al. The role of autophagy in resistance to targeted therapies. Cancer Treat Rev. 2020;88:102043.","journal-title":"Cancer Treat Rev"},{"key":"1426_CR39","doi-asserted-by":"publisher","first-page":"2439","DOI":"10.1007\/s13402-024-01032-7","volume":"47","author":"P Zhang","year":"2024","unstructured":"Zhang P, Chen S, Cai J, et al. GALNT6 drives lenvatinib resistance in hepatocellular carcinoma through autophagy and cancer-associated fibroblast activation. Cell Oncol (Dordr). 2024;47:2439\u201360.","journal-title":"Cell Oncol (Dordr)"},{"key":"1426_CR40","doi-asserted-by":"publisher","DOI":"10.1016\/j.canlet.2023.216405","volume":"576","author":"Y Zhang","year":"2023","unstructured":"Zhang Y, Zhang Y, Tao H, et al. Targeting LINC01607 sensitizes hepatocellular carcinoma to Lenvatinib via suppressing mitophagy. Cancer Lett. 2023;576:216405.","journal-title":"Cancer Lett"},{"key":"1426_CR41","doi-asserted-by":"publisher","first-page":"66","DOI":"10.1007\/s12672-023-00673-8","volume":"14","author":"D Gu","year":"2023","unstructured":"Gu D, Tong M, Wang J, et al. Overexpression of the lncRNA HOTAIRM1 promotes lenvatinib resistance by downregulating miR-34a and activating autophagy in hepatocellular carcinoma. Discov Oncol. 2023;14:66.","journal-title":"Discov Oncol"},{"key":"1426_CR42","doi-asserted-by":"publisher","first-page":"1066","DOI":"10.1038\/s41401-022-01021-2","volume":"44","author":"P Fernandez-Palanca","year":"2023","unstructured":"Fernandez-Palanca P, Payo-Serafin T, San-Miguel B, et al. Hepatocellular carcinoma cells loss lenvatinib efficacy in vitro through autophagy and hypoxia response-derived neuropilin-1 degradation. Acta Pharmacol Sin. 2023;44:1066\u201382.","journal-title":"Acta Pharmacol Sin"},{"key":"1426_CR43","doi-asserted-by":"publisher","DOI":"10.1016\/j.drup.2025.101224","volume":"81","author":"Z Zhang","year":"2025","unstructured":"Zhang Z, Zhou Q, Li Z, et al. DTX2 attenuates Lenvatinib-induced ferroptosis by suppressing docosahexaenoic acid biosynthesis through HSD17B4-dependent peroxisomal beta-oxidation in hepatocellular carcinoma. Drug Resist Updat. 2025;81:101224.","journal-title":"Drug Resist Updat"},{"key":"1426_CR44","doi-asserted-by":"publisher","DOI":"10.1016\/j.phymed.2024.155913","volume":"133","author":"Z Feng","year":"2024","unstructured":"Feng Z, Chan YT, Lu Y, et al. Siwu decoction suppress myeloid-derived suppressor cells through tumour cells necroptosis to inhibit hepatocellular carcinoma. Phytomedicine. 2024;133:155913.","journal-title":"Phytomedicine"},{"key":"1426_CR45","doi-asserted-by":"publisher","first-page":"863","DOI":"10.1134\/S0006297918080011","volume":"83","author":"KT Turpaev","year":"2018","unstructured":"Turpaev KT. Translation factor eIF5A, modification with hypusine and role in regulation of gene expression. eIF5A as a target for pharmacological interventions. Biochemistry (Mosc). 2018;83:863\u201373.","journal-title":"Biochemistry (Mosc)"},{"key":"1426_CR46","doi-asserted-by":"publisher","first-page":"373","DOI":"10.1038\/s41420-021-00764-x","volume":"7","author":"Y Zheng","year":"2021","unstructured":"Zheng Y, Li P, Huang H, et al. Androgen receptor regulates eIF5A2 expression and promotes prostate cancer metastasis via EMT. Cell Death Discov. 2021;7:373.","journal-title":"Cell Death Discov"},{"key":"1426_CR47","doi-asserted-by":"publisher","first-page":"1368","DOI":"10.3892\/ijo.2020.5143","volume":"57","author":"Y Tang","year":"2020","unstructured":"Tang Y, Chen K, Luan X, et al. Knockdown of eukaryotic translation initiation factor 5A2 enhances the therapeutic efficiency of doxorubicin in hepatocellular carcinoma cells by triggering lethal autophagy. Int J Oncol. 2020;57:1368\u201380.","journal-title":"Int J Oncol"},{"key":"1426_CR48","doi-asserted-by":"publisher","DOI":"10.1096\/fj.201903177R","volume":"35","author":"LR Padgett","year":"2021","unstructured":"Padgett LR, Robertson MA, Anderson-Baucum EK, et al. Deoxyhypusine synthase, an essential enzyme for hypusine biosynthesis, is required for proper exocrine pancreas development. FASEB J. 2021;35:e21473.","journal-title":"FASEB J"},{"key":"1426_CR49","doi-asserted-by":"publisher","first-page":"32","DOI":"10.1186\/s12964-023-01053-z","volume":"21","author":"M Hashemi","year":"2023","unstructured":"Hashemi M, Nadafzadeh N, Imani MH, et al. Targeting and regulation of autophagy in hepatocellular carcinoma: revisiting the molecular interactions and mechanisms for new therapy approaches. Cell Commun Signal. 2023;21:32.","journal-title":"Cell Commun Signal"}],"container-title":["Human Cell"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s13577-026-01426-9.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1007\/s13577-026-01426-9","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s13577-026-01426-9.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,7,18]],"date-time":"2026-07-18T03:58:05Z","timestamp":1784347085000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1007\/s13577-026-01426-9"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,7,18]]},"references-count":49,"journal-issue":{"issue":"8","published-online":{"date-parts":[[2026,8]]}},"alternative-id":["1426"],"URL":"https:\/\/doi.org\/10.1007\/s13577-026-01426-9","relation":{},"ISSN":["1749-0774"],"issn-type":[{"value":"1749-0774","type":"electronic"}],"subject":[],"published":{"date-parts":[[2026,7,18]]},"assertion":[{"value":"29 December 2025","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"11 July 2026","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"18 July 2026","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"The authors declare that they have no competing interests.","order":1,"name":"Ethics","label":"Conflict of interest","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"All authors have approved the manuscript and consented to its publication.","order":2,"name":"Ethics","label":"Consent for publication","group":{"name":"EthicsHeading","label":"Declarations"}}],"article-number":"110"}}